Personalizing Disease Management Through Technology Solutions: Part II - Vendor Landscape
Scope
Report Highlights
Reasons to Purchase
Table of Contents
- ABOUT DATAMONITOR - page 2
- CHAPTER 1 EXECUTIVE SUMMARY - page 3
- Introduction - page 3
- Market context - page 3
- Competitive dynamics - page 5
- Strategies for partnering with a disease management vendor - page 5
- Future decoded - page 6
- LIST OF FIGURES - page 10
- CHAPTER 2 KEY FINDINGS - page 11
- Scope of this report - page 11
- Key Findings - page 12
- Disease management programs are becoming an important part of the healthcare sector despite challenges - page 12
- Consumer, physician and payer demand will drive increasing levels of personalization in disease management - page 12
- Adoption of DM programs will be facilitated by technology (i.e. mobile devices) and an industry-wide trend towards interoperability - page 12
- Disease management programs should be viewed as part of a tool set to reinforce the patient-physician relationship - page 13
- A successful disease management program seamlessly integrates different players and achieves consistent intervention - page 13
- CHAPTER 3 MARKET CONTEXT - page 14
- Introduction - page 14
- Industry trends - page 14
- Key drivers - page 15
- CHAPTER 4 KEY FEATURES OF A DM PROGRAM - page 21
- Role of technology in disease management - page 23
- Key findings - page 23
- Emerging technologies that will influence disease management - page 24
- How profiled vendors map to individual key features - page 25
- CHAPTER 5 COMPETITIVE DYNAMICS - page 26
- Key findings and trends - page 26
- Overview of vendors - page 27
- Although DM vendors fall into one of the following categories, mergers and acquisitions will continue to transform the industry - page 27
- Profiles of select disease management vendors - page 28
- Alere Medical - page 28
- FutureHealth - page 29
- HealthMedia - page 30
- iMetrikus - page 31
- ParadigmHealth - page 32
- Current relative position of profiled vendors - page 33
- CHAPTER 6 STRATEGIES FOR PARTNERING WITH A DM VENDOR - page 34
- Formulating an effective disease management strategy - page 34
- Framework for evaluating a disease management vendor - page 35
- Challenges for DM vendors and other stakeholders - page 36
- THE FUTURE DECODED - page 37
- How will DM programs evolve - page 37
- The disease management value proposition - page 38
- APPENDIX - page 43
- Research Methodology - page 43
- Datamonitor Healthcare Technology Decision maker Panels - page 43
- Related Datatmonitor eHealthInsight research 2005-2006 - page 44
- Datamonitor eHealth Physician Insight Survey 2005 - page 44
- Datamonitor eHealth Consumer Insight Survey 2005 - page 45
- Related Datamonitor eHealthInsight research, 2005 - 2006 - page 45
- Analyst Contacts - page 48
- Research Methodology - page 43
- List of Figures
- Figure 1: Disease management in context: Consumers are becoming increasing involved in their health care - page 16
- Figure 2: Patient-focused disease management (DM) programs vary in the degree of intervention they provide - page 18
- Figure 3: End-user perspectives: Consumers - page 19
- Figure 4: End-user perspectives: Physicians - page 20
- Figure 5: Do your IT systems enable clinicians to view clinical and patient data from different departments within an integrated electronic medical record? (Yes/no) If not, what is your timeframe for enabling this integrated view? - page 24
- Figure 6: How profiled vendors map to individual key features - page 25
- Figure 7: Types of disease management vendors: Mergers and acquisitions will continue to shape the vendor landscape - page 27
- Figure 8: Current relative position of profiled vendors - page 33
- Figure 9: Framework for evaluating a disease management vendor - page 35
- Figure 10: Do you have plans (in the next 1-2 years) to increase the level of personalization such as the following? - page 37
- Figure 11: The disease management value proposition - page 39
- Figure 12: What type of technology-enabled services would you like when interacting with your doctor's office? - page 41
- Figure 13: The ideal DM program connects different stakeholders - page 42
Other users found this report page using the following search terms: personalized medicine pharmacogenomics pharmacogenetics pharmacoproteomics metabolomics
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.